 Dublin-based Trinity Biotech Plc shares TRIB, -4.24 jumped 6 premarket Monday, after the company said it has received approval from the World Health Organization for its HIV screening product, TrinScreen. The companys Uni-Gold HIV product has served as the main confirmatory test for the detection of HIV in Africa for many years. 